Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
According to Medtronic's latest financial reports the company's current EPS (TTM) is โน231.61. In 2022 the company made an earnings per share (EPS) of โน275.03 a decrease over its 2021 EPS that were of โน297.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน222.65 | -19.05% |
2022 | โน275.03 | -7.45% |
2021 | โน297.17 | 32.7% |
2020 | โน223.94 | -24.43% |
2019 | โน296.32 | 108.38% |
2018 | โน142.20 | -54.74% |
2017 | โน314.20 | 20.98% |
2016 | โน259.71 | 57.27% |
2015 | โน165.13 | -33.81% |
2014 | โน249.49 | -22.49% |
2013 | โน321.87 | 14.2% |
2012 | โน281.85 | 4.42% |
2011 | โน269.93 | 9.69% |
2010 | โน246.08 | 52.11% |
2009 | โน161.79 | -1.04% |
2008 | โน163.49 | -23.51% |
2007 | โน213.73 | 10.09% |
2006 | โน194.14 | 47.1% |
2005 | โน131.98 | -10.4% |
2004 | โน147.31 | 14.57% |
2003 | โน128.58 | 39.81% |
2002 | โน91.96 | 58.82% |
2001 | โน57.90 | -31.31% |
2000 | โน84.30 | 86.79% |
1999 | โน45.13 | 1.92% |
1998 | โน44.28 | -22.67% |
1997 | โน57.26 | 31.85% |
1996 | โน43.43 |